Free Trial

National Research (NRC) Stock Price, News & Analysis

-0.01 (-0.03%)
(As of 05/22/2024 ET)
Today's Range
50-Day Range
52-Week Range
57,063 shs
Average Volume
71,431 shs
Market Capitalization
$742.69 million
P/E Ratio
Dividend Yield
Price Target
NRC stock logo

About National Research Stock (NASDAQ:NRC)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

NRC Stock Price History

NRC Stock News Headlines

Herbert Lin
Alberta Innovates helping businesses succeed
See More Headlines
Receive NRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Ex-Dividend for 4/15 Dividend
Dividend Payable
Ex-Dividend for 7/15 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Commercial physical research
Current Symbol
Year Founded


Net Income
$30.97 million
Pretax Margin


Sales & Book Value

Annual Sales
$148.58 million
Cash Flow
$1.51 per share
Book Value
$1.55 per share


Free Float
Market Cap
$742.69 million

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Michael D. Hays (Age 69)
    Founder, CEO, President & Director
    Comp: $131.11k
  • Ms. Helen L. Hrdy (Age 59)
    Chief Customer Officer
    Comp: $291.51k
  • Mr. Christophe Louvion (Age 51)
    Chief Product & Technology Officer
  • Mr. Andy Monnich (Age 48)
    Chief Corporate Development Officer
  • Mr. Jon Boumstein
    Chief Delivery Officer
  • Dr. Gregory Makoul M.S.
    Ph.D., Chief Transformation Officer
  • Mr. Jason Hahn (Age 52)
    Chief Revenue Officer
  • Ms. Linda Stacy
  • Megan Charko
    Senior Manager of Content Marketing

NRC Stock Analysis - Frequently Asked Questions

How have NRC shares performed in 2024?

National Research's stock was trading at $39.56 on January 1st, 2024. Since then, NRC shares have decreased by 21.3% and is now trading at $31.14.
View the best growth stocks for 2024 here

When is National Research's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 6th 2024.
View our NRC earnings forecast

How were National Research's earnings last quarter?

National Research Co. (NASDAQ:NRC) announced its quarterly earnings results on Tuesday, February, 11th. The company reported $0.34 earnings per share for the quarter. The firm earned $32.62 million during the quarter. National Research had a net margin of 20.60% and a trailing twelve-month return on equity of 54.83%.

How often does National Research pay dividends? What is the dividend yield for National Research?

National Research announced a quarterly dividend on Tuesday, May 7th. Shareholders of record on Friday, June 28th will be given a dividend of $0.12 per share on Monday, July 15th. This represents a $0.48 annualized dividend and a dividend yield of 1.54%. The ex-dividend date is Friday, June 28th.
Read our dividend analysis for NRC

Is National Research a good dividend stock?

National Research (NASDAQ:NRC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.53%. The dividend payout ratio is 38.71%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for NRC.

What is Michael D. Hays' approval rating as National Research's CEO?

85 employees have rated National Research Chief Executive Officer Michael D. Hays on Michael D. Hays has an approval rating of 87% among the company's employees.

What other stocks do shareholders of National Research own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD).

Who are National Research's major shareholders?

National Research's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.96%), Conestoga Capital Advisors LLC (3.29%), QV Investors Inc. (1.44%), iA Global Asset Management Inc. (0.80%), Norden Group LLC (0.55%) and Public Employees Retirement System of Ohio (0.33%). Insiders that own company stock include Amandla Mk Trust, Jona S Raasch and Kevin R Karas.
View institutional ownership trends

How do I buy shares of National Research?

Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does National Research have any subsidiaries?
The following companies are subsidiares of National Research: National Research Corporation Canada, PatientWisdom Inc., and The Governance Institute.
Read More
This page (NASDAQ:NRC) was last updated on 5/23/2024 by Staff

From Our Partners